IRONWOOD PHARMACEUTICALS, INC. Payments of Derivative Issuance Costs
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Payments of Derivative Issuance Costs of $21.10 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDerivativeIssuanceCosts · last filed 2023-11-09
- IRONWOOD PHARMACEUTICALS, INC. payments of derivative issuance costs for the quarter ending 2017-09-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. payments of derivative issuance costs for the quarter ending 2017-06-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. payments of derivative issuance costs for the quarter ending 2017-03-31 was $21.10M, a 0.00% change year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. payments of derivative issuance costs for the quarter ending 2016-09-30 was $0.00.
| Period end | Payments of Derivative Issuance Costs 1 month | Payments of Derivative Issuance Costs 3 month | Payments of Derivative Issuance Costs 6 month | Payments of Derivative Issuance Costs 9 month |
|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $21.10M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $21.10M 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | $21.10M 10-Q · filed 2017-05-08 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $21.10M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $21.10M 10-Q · filed 2016-08-08 | ||
| 2016-03-31 | $21.10M 10-Q · filed 2016-05-10 | |||
| 2015-06-30 | $21.10M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |